{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:23981",
      "entity_text" : "EU",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:Q9P0L2",
      "entity_text" : "mark",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "There are different aspects that are being taken into consideration for classification : grade of invasiveness, duration of contact with the body, and local versus systemic effect.7, 23 In order to obtain the CE mark that allows marketing of a medical device in the EU,24 the manufacturer is obliged to identify and describe the risks detected during the pre-market phase.1, 5 The risk management file (RMF) of the medical device or its family should contain clear definitions of the hazardous situations associated with use of the medical device.",
  "reading_complete" : "2020-08-05T21:14:56Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-05T21:13:56Z",
  "trigger" : "allows",
  "evidence" : [ "mark that allows marketing of a medical device in the EU" ],
  "pmc_id" : "6771951",
  "score" : 0
}